Skip to main content

A roundup of what The Globe and Mail’s market strategist Scott Barlow is reading today on the Web

A potential breakthrough in the U.K.’s Brexit negotiations with the EU highlights a very interesting trade idea from Citi strategist Chris Montague.

Earlier this week, Mr. Montague published a report arguing persuasively that U.K. companies with more than 50 per cent of revenue in U.S. dollars are currently unfairly discounted – trading at stock prices understating future profits.

Story continues below advertisement

A list of stocks uncovers undervalued British companies with strong global presences in health care (like GlaxoSmithKline PLC, with a yield of 4.8 per cent) , leisure (Carnival PLC), and commodities (British Petroleum PLC, 6.6 per cent dividend).

Investors will have to be careful to buy the stock in a way that keeps the full benefit of dividends (foreign holdings tax is in play in some cases). There remains considerable political risk, so the opportunity should be limited to risk-tolerant investors.

“ @SBarlow_ROB C: Undervalued U.K. and EU USD earners” – (full table of stock ideas) Twitter

“European Commission President Jean-Claude Juncker says a Brexit deal has been reached” – Bloomberg

***

Scotia analyst Hugo Ste-Marie predicts mediocre TSX profit growth in the upcoming earnings season,

“Q3/19 EPS Running out of Steam. Bottom-up consensus projects TSX Q3/19 EPS at $267, 2.3% below Q2/19 ($273, most profitable quarter since Q3/08). Earnings growth remains positive on a YoY basis (+1.2%), but stands noticeably lower than 2016 to 2018. On a 12M trailing basis, TSX EPS should ascend to a new high of $1,041 in Q3/19 (+0.3% YoY). Still, positive growth is visibly in danger of negative surprises.”

Story continues below advertisement

Mr. Ste-Marie is much more optimistic about domestic profits in 2020 thanks to a stabilizing housing market and improving global economic growth.

“SBarlow_ROB Scotia: "Q3/19 EPS Running out of Steam'” – (research excerpt) Twitter

***

The strategy team at Morgan Stanley has produced a list of long and short ideas going into earnings. They expect companies like Boston Scientific Corp., Deere & Co. and Microsoft Corp. to beat estimates and rise. They expect profit misses or reduced for guidance for United Parcel Service Inc. and Proctor & Gamble Co..

“@SBarlow_ROB MS: Long and short ideas into earnings” – (full list) Twitter

***

Story continues below advertisement

Nomura strategist Masanari Takada focuses on the world’s most speculative and aggressive large funds to predict market direction. In his report released Thursday, he provided hopes for an upcoming risk-on rally,

“We expect little clear direction in sentiment until around 5 November, but we see this as a period in which the market will be laying the foundation for the next risk-on phase (which we expect to begin on or around 5 November) … US equity sentiment seems to have formed a double bottom with troughs in August and October, and this may be a positive sign. This pattern suggests that US equity supply and demand is likely to take a turn for the better toward the end of the year”

“@SBarlow_ROB Nomura’s Takada: Risk-on rally ahead” – (research excerpt) Twitter

***

Tweet of the Day:

Diversion: “Wildlife photographer of the year 2019 winners – in pictures” – The Guardian

Story continues below advertisement

Newsletter: “Bonds aren’t doing their job for investors” – Globe Investor

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter